Polycystic kidney disease

The Lillian Jean Kaplan International Prize is the most prestigious prize in the polycystic kidney disease field; it recognizes individuals whose scientific work results in tangible achievement toward improving the knowledge and treatment of the disease. York Pei, M.D.
Both also honorary lecturers this month at the World Congress of Nephrology in Melbourne, Australia. Andy Betts, CEO of the Kansas City, Missouri-based PKD Foundation, presented the awards during the Congress. “I am extremely honored to  included among such a prestigious group of investigators.” and would like to thank the Kaplan family for the continued support of the PKD Research Foundation and of this award mechanism.”

Remarkable and unexpected discoveries

“In reality,” said Yoder, “the recognition of these accomplishments should given to a large number of students and fellows that have worked in my laboratory over the past 20 years. So their efforts have led to some remarkable and unexpected discoveries into the basic cellular mechanisms that underlie this disorder. But hopefully, in the near future, with continued advances, we will able to find better approaches to slow the progression or even preventing cyst formation.”
Therefore the polycystic kidney disease, or PKD, is one of the most common life-threatening disorders in the world, affecting 12.4 million people. But it is a chronic, genetic disease; by uncontrolled growth of cysts in the kidneys and other organs that can lead to kidney failure. As of today, there is no known cure and only one known treatment to slow the decline of the disease.

Ascertaining the function